Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Anaphylactic shock | x | x | ||
| Anaemia megaloblastic | x | x | ||
| Anorexia | x | x | ||
| Toxic epidermal necrolysis | x | x | ||
| Erythema multiforme | x | x | ||
| Haematuria | x | x | ||
| Hypersensitivity | x | x | ||
| Leukopenia | x | x | ||
| Pancytopenia | x | x | ||
| Pulmonary eosinophilia | x | x | ||
| Stevens-Johnson syndrome | x | x | ||
| Thrombocytopenia | x | x | ||
| Vomiting | x | x | ||
| Atrophic glossitis | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||
|---|---|---|---|---|
| Malaria | x | |||
| Toxoplasmosis | x | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |